Multimodality Treatment for Esophageal Cancer: The Role of Surgery and Neoadjuvant Therapy

Makary, Martin A.; Kiernan, Paul D.; Sheridan, Michael J.; Tonnesen, Glen; Hetrick, Vivian; Vaughan, Betty; Graling, Paula; Elster, Eric
August 2003
American Surgeon;Aug2003, Vol. 69 Issue 8, p693
Academic Journal
Treatment of esophageal cancer has traditionally included surgery as the initial modality. Neoadjuvant chemoradiation therapy has been introduced with the goal of downstaging tumors before surgical resection; however, its role in esophageal cancer remains controversial. We report 116 patients who underwent esophagogastrectomy with reconstruction for carcinoma of the esophagus or esophagogastric junction over a 10-year period (January 1,1990 to June 1, 2001). Forty patients underwent neoadjuvant radiation and chemotherapy followed by surgery. Hospital mortality in this group was 7.5 per cent, complete pathologic response (CPR) was 37.5 per cent, and overall 3- and 5-year survival rates were 47 and 38 per cent. Five-year survival in the 15 patients with CPR was 85 per cent. Five patients underwent neoadjuvant single-agent therapy (four chemotherapy and one radiation) followed by surgery, and none survived to 3 years. Seventy-one patients underwent surgery without neoadjuvant therapy. Hospital mortality in this group was 1.4 per cent, with 3- and 5-year survival of 21 and 17 per cent--a decreased long-term survival compared with the neoadjuvant therapy group despite the observation that patients who underwent neoadjuvant therapy had a larger tumor size on presentation (5.5 ± 0.4 cm vs 3.8 ± 0.2 cm; P = 0.002). Squamous cell carcinomas seemed to be more responsive to neoadjuvant radiation and chemotherapy followed by surgery than were adenocarcinomas, with a CPR of 44.4 versus 35.5 per cent; however, 5-year survival rates in these complete responders were not significantly different (100% and 78%, respectively; P = 0.97). We report that esophagogastrectomy in...


Related Articles

  • Learning curve of video-assisted thoracoscopic esophagectomy and extensive lymphadenectomy for squamous cell cancer of the thoracic esophagus and results. Osugi, H.; Takemura, M.; Higashino, M.; Takada, N.; Lee, S.; Ueno, M.; Tanaka, Y.; Fukuhara, K.; Hashimoto, Y.; Fujiwara, Y.; Kinoshita, H. // Surgical Endoscopy;Mar2003, Vol. 17 Issue 3, p515 

    Background: The efficacy of thoracoscopic radical esophagectomy for cancer of the thoracic esophagus and the learning curve required have yet to be clearly established. Methods: Eighty treatment-naive patients with esophageal cancer without contiguous spread underwent esophageal mobilization and...

  • A case involving long-term survival after esophageal cancer with liver and lung metastases treated by multidisciplinary therapy: report of a case. Iitaka, Daisuke; Shiozaki, Atsushi; Fujiwara, Hitoshi; Ichikawa, Daisuke; Okamoto, Kazuma; Komatsu, Shuhei; Murayama, Yasutoshi; Ikoma, Hisashi; Kuriu, Yoshiaki; Nakanishi, Masayoshi; Ochiai, Toshiya; Kokuba, Yukihito; Sonoyama, Teruhisa; Otsuji, Eigo // Surgery Today;May2013, Vol. 43 Issue 5, p556 

    A 57-year-old male with lower esophageal cancer underwent subtotal esophagectomy with lymphadenectomy. The histopathological diagnosis was poorly differentiated squamous cell carcinoma, pT2N1M0 pStageIIB. After one course of postoperative adjuvant chemotherapy involving low-dose CDDP/5FU, a...

  • The presence of lymphovascular and perineural infiltration after neoadjuvant therapy and oesophagectomy identifies patients at high risk for recurrence. Lagarde, S M; Phillips, A W; Navidi, M; Disep, B; Immanuel, A; Griffin, S M // British Journal of Cancer;11/17/2015, Vol. 113 Issue 10, p1427 

    Background: In patients treated for oesophageal cancer the importance of lymphovascular and perineural invasion (PNI) after neoadjuvant therapy has yet to be established. The aim of this study was to assess the incidence and prognostic significance of these factors in a consecutive...

  • Surgical treatment of superficial esophageal cancer. Tachibana, Mitsuo; Kinugasa, Shoichi; Shibakita, Muneaki; Tonomoto, Yasuhito; Hattori, Shinji; Hyakudomi, Ryoji; Yoshimura, Hiroshi; Dhar, Dipok; Nagasue, Naofumi // Langenbeck's Archives of Surgery;Sep2006, Vol. 391 Issue 4, p304 

    The worldwide incidence of superficial esophageal cancer (SEC) is increasing. The aim of this study is to review the systematic surgical outcomes of esophagectomy for SEC. Only manuscripts written in English and written between 1980 and 2003 were selected from MEDLINE. The keywords consisting of...

  • P-0007TREATMENT OF LOCALLY ADVANCED ESOPHAGEAL CANCER WITH MULTIMODAL COMPONENT. Zhetkergen, Arzykulov; Yergen, Izhanov; Abzalbek, Yestay; Kairbekova, Dinara; Akhetov, Marat // Annals of Oncology;Jun2013, Vol. 24 Issue suppl_4, piv39 

    No abstract available.

  • DISCUSSION.  // American Surgeon;Jun2009, Vol. 75 Issue 6, p497 

    The article presents a discussion of the paper on the treatment of esophageal malignancy through surgery by Doctor Paul D. Kiernan and colleagues. According to Kiernan, the safest reconstruction was offered by the transhiatal resection. The complete pathologic response rate (CPR) with squamous...

  • Improved Prognosis of Resected Esophageal Cancer World J. Surg. Vol. 28, No. 6, June 2004. Stein, Hubert J.; Siewert, Jorg-Rudiger // World Journal of Surgery;Jun2004, Vol. 28 Issue 6, p520 

    Because of the perceived high risk of esophagectomy and the assumed poor long-term results, the role of surgical resection as the mainstay of treatment for localized esophageal cancer is currently being challenged. Early tumors are increasingly approached by endoscopic mucosectomy or mucosal...

  • Treatment of more advanced cancer. Lundell, L. // Journal of the Royal College of Surgeons of Edinburgh;Aug2000, Vol. 45 Issue 4, p270 

    Describes the treatment of more advanced oesophageal cancer. Incidence of squamous cell carcinoma and adenocarcinoma of the esophagus; Shift of the biological behavior of oesophageal cancer; Immature differentiation and greater nodal involvement; Combination of chemo- and radiotherapy and...

  • P-0059INTERIM SAFETY RESULTS FROM A RANDOMIZED TRIAL OF ADJUVANT CHEMOTHERAPY WITH LV5FU2 VS. FOLFOX FOR ESOPHAGEAL SQUAMOUS CELL CARCINOMA. Park, Se Hoon; Lee, Jeeyun; Choi, Yong Soo; Zo, Jae; Shim, Young Mok // Annals of Oncology;Jun2013, Vol. 24 Issue suppl_4, piv53 

    No abstract available.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics